iShares Biotechnology ETF (IBB)

NasdaqGM: IBB · 即時價格 · USD

202.93

+0.29 (0.14%)

收盤價： Sep 11, 2026, 3:59 PM

203.02

+0.04%

盤後: 7:30 PM

提醒

Alert

股價、關鍵數字和最新消息，都在這一頁。

0.14% (1D)

買價	185.09
市值	n/a
營收 (ttm)	n/a
淨利（ttm）	n/a
	0.00
	n/a
	25.35
	n/a
P/B (ttm)	1.26
P/S (ttm)	0.00
財報日期	n/a

賣價	197.12
成交量	2,281,774
20 日平均成交量	1,588,100
開盤價	203.96
前收盤價	202.64
當日區間	202.75 - 205.30
52 週範圍	138.79 - 217.12
分析師	n/a
目標價	n/a
股利	n/a
除息日	n/a

關於 IBB

The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified....

[閱讀更多]

產業 n/a

類股 n/a

IPO 日期 Feb 12, 2001

員工 n/a

證券交易所 NasdaqGM

股票代號 IBB

完整的公司簡介

財務表現

iShares Biotechnology ETF 在 undefined 年的營收為 n/a，較前一年的 n/a 增加 undefined%。淨利為 n/a，較前期增加 undefined%。

財務報表

財報驚奇

iShares Biotechnology ETF 已於 Invalid Date 公布季度財報：

營收為 n/a 低於預期 $0, 年增 NaN% 成長.
每股盈餘為低於預期 , 年增 NaN% 成長.

價格為何變動

新聞動態

2 週前 · MT Newswires

Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Friday Ahead of Warsh Speech

The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.1% and the actively trad

2 週前 · MT Newswires

Exchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Thursday Ahead of Fed's Jackson Hole Symposium

The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.6%, and the actively tra

2 週前 · 24/7 Wall St.

Moderna Drops 7% Despite a Fresh Wolfe Research Upgrade, BioNTech Slips

Moderna stock shed 7% on Wednesday with no company news to blame, reopening a brutal question that its 439% year-to-date rally had been drowning out: what exactly does a $59 billion valuation buy on a...

2 週前 · MT Newswires

Exchange-Traded Funds Lower, Equity Futures Mixed Pre-Bell Wednesday Amid Inflation Data Release

The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was down 0.1%, and the actively t

2 週前 · 24/7 Wall St.

Merck Just Gained 19% in a Month. What Would It Take to Get MRK Stock Up to $200?

Merck stock sits near analyst targets that fall short of $200, yet a compressed fall calendar of FDA decisions and a pivotal cancer vaccine readout could force Wall Street to rethink the entire post-K...

第 1 頁，共 2 頁

iShares Biotechnology ETF (IBB)